Details werden geladen...
https://connections.cu.edu/stories/inside-cu-anschutz-clinical-trial-new-oral-glp-1-weight-loss-drug
Inside a CU Anschutz clinical trial for a new oral GLP-1 weight loss drug | CU Connections
Patients and researchers at CU Anschutz are part of a trial testing orforglipron – a daily, non-peptide pill that could reshape how GLP-1 therapies are delivered.
Ähnliche Seiten
Eli Lilly’s obesity drug shows up to 30% weight loss in trial - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/eli-lillys-obesity-drug-shows-up-to-30-weight-loss-in-trial/articleshow/131249598.cms
Weight-loss drugs present new hope for adults with asthma
https://refractor.io/disease/obesity/weight-loss-drugs-adults-asthma/
Trial of next-gen weight-loss drug retatrutide brings it one step closer to FDA approval | Scientific American
https://www.scientificamerican.com/article/next-gen-weight-loss-drug-retatrutide-trial-brings-it-one-step-closer-to-fda-approval/
New Weight-Loss Pill Could Help Solve a Major Problem With GLP-1 Drugs : ScienceAlert
https://www.sciencealert.com/new-weight-loss-pill-could-help-solve-a-major-problem-with-glp-1-drugs
A new weight loss drug shows dramatic results. Here’s how much better it performs vs. Ozempic
https://www.ctvnews.ca/health/article/a-new-weight-loss-drug-shows-dramatic-results-heres-how-much-better-it-performs-vs-ozempic/